These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 8164837)
1. Oral administration of semisynthetic sphingolipids promotes recovery of striatal dopamine concentrations in a murine model of parkinsonism. Schneider JS; DiStefano L Neurology; 1994 Apr; 44(4):748-50. PubMed ID: 8164837 [TBL] [Abstract][Full Text] [Related]
2. LIGA 20 increases striatal dopamine levels in aged MPTP-treated mice refractory to GM1 ganglioside treatment. Schneider JS; DiStefano L Neuroreport; 1993 Nov; 5(2):103-4. PubMed ID: 8110995 [TBL] [Abstract][Full Text] [Related]
3. Response of the damaged dopamine system to GM1 and semisynthetic gangliosides: effects of dose and extent of lesion. Schneider JS; Distefano L Neuropharmacology; 1995 May; 34(5):489-93. PubMed ID: 7566482 [TBL] [Abstract][Full Text] [Related]
4. Recovery from experimental parkinsonism in primates with GM1 ganglioside treatment. Schneider JS; Pope A; Simpson K; Taggart J; Smith MG; DiStefano L Science; 1992 May; 256(5058):843-6. PubMed ID: 1350379 [TBL] [Abstract][Full Text] [Related]
5. GM1 ganglioside treatment promotes recovery of striatal dopamine concentrations in the mouse model of MPTP-induced parkinsonism. Schneider JS; Yuwiler A Exp Neurol; 1989 Aug; 105(2):177-83. PubMed ID: 2568945 [TBL] [Abstract][Full Text] [Related]
6. GM1 ganglioside-induced recovery of nigrostriatal dopaminergic neurons after MPTP: an immunohistochemical study. Hadjiconstantinou M; Mariani AP; Neff NH Brain Res; 1989 Apr; 484(1-2):297-303. PubMed ID: 2565752 [TBL] [Abstract][Full Text] [Related]
7. Effects of age on GM1 ganglioside-induced recovery of concentrations of dopamine in the striatum in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice. Schneider JS Neuropharmacology; 1992 Feb; 31(2):185-92. PubMed ID: 1553028 [TBL] [Abstract][Full Text] [Related]
8. GM1 gangliosides alter acute MPTP-induced behavioral and neurochemical toxicity in mice. Fazzini E; Durso R; Davoudi H; Szabo GK; Albert ML J Neurol Sci; 1990 Oct; 99(1):59-68. PubMed ID: 2250172 [TBL] [Abstract][Full Text] [Related]
9. MPTP-induced parkinsonism: acceleration of biochemical and behavioral recovery by GM1 ganglioside treatment. Schneider JS J Neurosci Res; 1992 Jan; 31(1):112-9. PubMed ID: 1613817 [TBL] [Abstract][Full Text] [Related]
10. [Study of extracellular concentration of dopamine and its metabolites in mice striatum by a microdialysis technique at intraperitoneal administration of MPTP]. Averkin RG; Korshunov VA; Shchegolevskiĭ NV; Mats VN; Markevich VA; Grigor'ian GA; Bazian AS Zh Vyssh Nerv Deiat Im I P Pavlova; 2010; 60(1):109-19. PubMed ID: 20352690 [TBL] [Abstract][Full Text] [Related]
11. Treatment with GM1 ganglioside restores striatal dopamine in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse. Hadjiconstantinou M; Neff NH J Neurochem; 1988 Oct; 51(4):1190-6. PubMed ID: 3262149 [TBL] [Abstract][Full Text] [Related]
12. [Effect of acidic fibroblast growth factor on experimental parkinsonism and levels of dopamine and its metabolites in the striatum of mice of various ages]. Kucherianu VG; Kryzhanovskiĭ GN; Kudrin VS; Iurasov VV; Nikushkin EV; Zhigal'tsev IV Biull Eksp Biol Med; 1999 May; 127(5):502-5. PubMed ID: 10399565 [No Abstract] [Full Text] [Related]
13. [Recovery of nigrostriatal and mesolimbic dopaminergic system following administration of ganglioside in MPTP-treated mice]. Date I; Asari S; Nishimoto A; Felten DL No To Shinkei; 1990 Nov; 42(11):1035-40. PubMed ID: 2076347 [TBL] [Abstract][Full Text] [Related]
14. Effects of GM1 ganglioside treatment on dopamine innervation of the striatum of MPTP-treated mice. Rothblat DS; Schneider JS Ann N Y Acad Sci; 1998 Jun; 845():274-7. PubMed ID: 9668361 [TBL] [Abstract][Full Text] [Related]
15. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration to C57-black mice leads to parallel decrements in neostriatal dopamine content and tyrosine hydroxylase activity. Mayer RA; Walters AS; Heikkila RE Eur J Pharmacol; 1986 Jan; 120(3):375-7. PubMed ID: 2868908 [TBL] [Abstract][Full Text] [Related]
17. Suppression of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity in mouse brain by piroheptine and trihexyphenidyl. Saitoh T J Neurol Sci; 1988 Feb; 83(2-3):161-6. PubMed ID: 3258627 [TBL] [Abstract][Full Text] [Related]
18. Administration of GM1 ganglioside restores the dopamine content in striatum after chronic treatment with MPTP. Hadjiconstantinou M; Rossetti ZL; Paxton RC; Neff NH Neuropharmacology; 1986 Sep; 25(9):1075-7. PubMed ID: 3490632 [TBL] [Abstract][Full Text] [Related]
19. Characterization of the neurotoxic potential of m-methoxy-MPTP and the use of its N-ethyl analogue as a means of avoiding exposure to a possible Parkinsonism-causing agent. Zimmerman DM; Cantrell BE; Reel JK; Hemrick-Luecke SK; Fuller RW J Med Chem; 1986 Aug; 29(8):1517-20. PubMed ID: 3488406 [TBL] [Abstract][Full Text] [Related]
20. Exogenous GM1 gangliosides induce partial recovery of the nigrostriatal dopaminergic system in MPTP-treated young mice but not in aging mice. Date I; Felten SY; Felten DL Neurosci Lett; 1989 Dec; 106(3):282-6. PubMed ID: 2601883 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]